The Peter MacCallum Cancer Centre, also known as the Peter MacCallum Cancer Institute and commonly abbreviated as Peter Mac, is an Australian oncology research institute, cancer treatment and ...

and the Peter MacCallum Cancer Centre (Peter Mac) have discovered a unique type of immune cell known as stem-like T cells, which is essential for maintaining potent, long-term immune responses.

SLAM-ITseq identifies that Nrf2 induces liver regeneration through the pentose phosphate pathway, Developmental Cell (2024). DOI: 10.1016/j.devcel.2024.01.024 Provided by Peter MacCallum Cancer Centre ...

Victoria-based Peter MacCallum Cancer Centre is to replace its eight-year-old high performance compute (HPC) and storage infrastructure. The public hospital’s HPC is used by 700 staff primarily ...

The Peter Mac Cup was introduced in 1993 and is designed to raise funds and awareness of the Peter MacCallum Cancer Centre. Each year one of the matches between Carlton and Collingwood is selected as ...

An international clinical trial led by Melbourne's Peter MacCallum Cancer Center (Peter Mac) has shown that adding the immunotherapy drug nivolumab to the chemotherapy that breast cancer patients ...

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ahead of surgery can dramatically improve breast cancer cure rates.

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders – T cells – lose their ability to function effectively.

Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders, T cells, to lose their ability to act efficiently.